PML-RARA Fusion Transcripts Detectable 8 Months prior to Promyelocytic Blast Crisis in Chronic Myeloid Leukemia

Promyelocytic blast crisis arising from chronic myeloid leukemia (CML) is rare. We present a 40-year-old male who developed promyelocytic blast crisis 17 months after CML diagnosis, confirmed by the presence of the t(15;17) and t(9;22) translocations in the leukemic cells. Preserved nucleic acids fr...

Full description

Saved in:
Bibliographic Details
Main Authors: Stephanie Wolanin, Robert K. McCall, Mark J. Pettenati, Michael W. Beaty, Giovanni Insuasti-Beltran, Bayard L. Powell, Stacey S. O’Neill
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Case Reports in Hematology
Online Access:http://dx.doi.org/10.1155/2020/8830595
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832553490845532160
author Stephanie Wolanin
Robert K. McCall
Mark J. Pettenati
Michael W. Beaty
Giovanni Insuasti-Beltran
Bayard L. Powell
Stacey S. O’Neill
author_facet Stephanie Wolanin
Robert K. McCall
Mark J. Pettenati
Michael W. Beaty
Giovanni Insuasti-Beltran
Bayard L. Powell
Stacey S. O’Neill
author_sort Stephanie Wolanin
collection DOAJ
description Promyelocytic blast crisis arising from chronic myeloid leukemia (CML) is rare. We present a 40-year-old male who developed promyelocytic blast crisis 17 months after CML diagnosis, confirmed by the presence of the t(15;17) and t(9;22) translocations in the leukemic cells. Preserved nucleic acids from routine BCR-ABL1 testing provided a unique opportunity to evaluate clonal progression over time. Retrospective analysis demonstrated PML-RARA fusion transcripts were first detectable 8 months prior to blast crisis presentation. A review of 21 cases of promyelocytic blasts crisis published in the literature reveals a male predominance with earlier age at onset as compared to females. Interestingly, TKI therapy during chronic phase did not impact the time interval between diagnosis and promyelocytic blast crisis. Treatment with standard acute promyelocytic leukemia regimens provides more favorable outcomes with complete molecular remission. Although rare, it is important to consider a promyelocytic blast crisis when evaluating for transformation of CML due to its effective treatment with specific therapies.
format Article
id doaj-art-ac6b125e32014a94aac2c3874ce1f702
institution Kabale University
issn 2090-6560
2090-6579
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Case Reports in Hematology
spelling doaj-art-ac6b125e32014a94aac2c3874ce1f7022025-02-03T05:53:54ZengWileyCase Reports in Hematology2090-65602090-65792020-01-01202010.1155/2020/88305958830595PML-RARA Fusion Transcripts Detectable 8 Months prior to Promyelocytic Blast Crisis in Chronic Myeloid LeukemiaStephanie Wolanin0Robert K. McCall1Mark J. Pettenati2Michael W. Beaty3Giovanni Insuasti-Beltran4Bayard L. Powell5Stacey S. O’Neill6Wake Forest Baptist Medical Center, Department of Pathology, Winston-Salem, NC, USAMolecular Pathology Laboratory Network, Maryville, TN, USAWake Forest Baptist Medical Center, Department of Pathology, Winston-Salem, NC, USAWake Forest Baptist Medical Center, Department of Pathology, Winston-Salem, NC, USAWake Forest Baptist Medical Center, Department of Pathology, Winston-Salem, NC, USAWake Forest Baptist Comprehensive Cancer Center, Section on Hematology and Oncology, Winston-Salem, NC, USAWake Forest Baptist Medical Center, Department of Pathology, Winston-Salem, NC, USAPromyelocytic blast crisis arising from chronic myeloid leukemia (CML) is rare. We present a 40-year-old male who developed promyelocytic blast crisis 17 months after CML diagnosis, confirmed by the presence of the t(15;17) and t(9;22) translocations in the leukemic cells. Preserved nucleic acids from routine BCR-ABL1 testing provided a unique opportunity to evaluate clonal progression over time. Retrospective analysis demonstrated PML-RARA fusion transcripts were first detectable 8 months prior to blast crisis presentation. A review of 21 cases of promyelocytic blasts crisis published in the literature reveals a male predominance with earlier age at onset as compared to females. Interestingly, TKI therapy during chronic phase did not impact the time interval between diagnosis and promyelocytic blast crisis. Treatment with standard acute promyelocytic leukemia regimens provides more favorable outcomes with complete molecular remission. Although rare, it is important to consider a promyelocytic blast crisis when evaluating for transformation of CML due to its effective treatment with specific therapies.http://dx.doi.org/10.1155/2020/8830595
spellingShingle Stephanie Wolanin
Robert K. McCall
Mark J. Pettenati
Michael W. Beaty
Giovanni Insuasti-Beltran
Bayard L. Powell
Stacey S. O’Neill
PML-RARA Fusion Transcripts Detectable 8 Months prior to Promyelocytic Blast Crisis in Chronic Myeloid Leukemia
Case Reports in Hematology
title PML-RARA Fusion Transcripts Detectable 8 Months prior to Promyelocytic Blast Crisis in Chronic Myeloid Leukemia
title_full PML-RARA Fusion Transcripts Detectable 8 Months prior to Promyelocytic Blast Crisis in Chronic Myeloid Leukemia
title_fullStr PML-RARA Fusion Transcripts Detectable 8 Months prior to Promyelocytic Blast Crisis in Chronic Myeloid Leukemia
title_full_unstemmed PML-RARA Fusion Transcripts Detectable 8 Months prior to Promyelocytic Blast Crisis in Chronic Myeloid Leukemia
title_short PML-RARA Fusion Transcripts Detectable 8 Months prior to Promyelocytic Blast Crisis in Chronic Myeloid Leukemia
title_sort pml rara fusion transcripts detectable 8 months prior to promyelocytic blast crisis in chronic myeloid leukemia
url http://dx.doi.org/10.1155/2020/8830595
work_keys_str_mv AT stephaniewolanin pmlrarafusiontranscriptsdetectable8monthspriortopromyelocyticblastcrisisinchronicmyeloidleukemia
AT robertkmccall pmlrarafusiontranscriptsdetectable8monthspriortopromyelocyticblastcrisisinchronicmyeloidleukemia
AT markjpettenati pmlrarafusiontranscriptsdetectable8monthspriortopromyelocyticblastcrisisinchronicmyeloidleukemia
AT michaelwbeaty pmlrarafusiontranscriptsdetectable8monthspriortopromyelocyticblastcrisisinchronicmyeloidleukemia
AT giovanniinsuastibeltran pmlrarafusiontranscriptsdetectable8monthspriortopromyelocyticblastcrisisinchronicmyeloidleukemia
AT bayardlpowell pmlrarafusiontranscriptsdetectable8monthspriortopromyelocyticblastcrisisinchronicmyeloidleukemia
AT staceysoneill pmlrarafusiontranscriptsdetectable8monthspriortopromyelocyticblastcrisisinchronicmyeloidleukemia